Advanced Search

Chimeric Antigen Receptor T Cell Stocks List

Symbol Grade Name % Change
GRCL A Gracell Biotechnologies Inc. -3.83
NKTX A Nkarta, Inc. -1.78
TSVT C 2seventy bio, Inc. 4.84
NTLA C Intellia Therapeutics, Inc. 0.06
PSTX C Poseida Therapeutics, Inc. 3.96
ACET C Adicet Bio, Inc. 1.63
HGEN D Humanigen, Inc. 0.89
JANX D Janux Therapeutics, Inc. -3.54
CRBU D Caribou Biosciences, Inc. -4.17
View As Page of Charts
Related Industries: Biotechnology Drug Manufacturers-General
Related Stock Lists: Immune System Medicine Biopharmaceutical Cancer Clinical Medicine Biotechnology Chimeric Antigen Receptor Gene Therapy Lymphoma Cancer Immunotherapy Life Sciences Solid Tumors Antigen Biology Breakthrough Therapy Cancer Treatment CD19 Hematopoietic Stem Cell Immunotherapy Leukemia

Related ETFs - A few ETFs which own one or more of the above listed Chimeric Antigen Receptor T Cell stocks.

Symbol Grade Name Weight
XDNA B Kelly CRISPR & Gene Editing Technology ETF 11.67
GNOM C Global X Genomics & Biotechnology ETF 4.57
BBC C Virtus LifeSci Biotech Clinical Trials ETF 3.96
MSGR B Direxion mRNA ETF 3.76
CBLS D Changebridge Capital Long/Short Equity ETF 3.7
View all Chimeric Antigen Receptor T Cell ETFs...
Compare ETFs
Compare GNOM to MSGR Compare MSGR to CBLS Compare XDNA to MSGR

Chimeric Antigen Receptor T Cell Stocks Recent News

Date Stock Title
May 20 NKTX Nkarta: A Promising Natural Killer Cell Play
May 20 JANX Janux Therapeutics (NASDAQ:JANX) Is In A Strong Position To Grow Its Business
May 19 GRCL Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences
May 19 CRBU Crispred CAR-T Cells In The Clinic
May 18 ACET Adicet Bio to Present at Upcoming Investor Conferences
May 18 NKTX What Makes Nkarta, Inc. (NKTX) a New Buy Stock
May 18 NKTX Can Nkarta, Inc. (NKTX) Climb 383% to Reach the Level Wall Street Analysts Expect?
May 18 PSTX Poseida Therapeutics Appoints Charles M. Baum, M.D., Ph.D., to Board of Directors
May 17 CRBU Caribou Biosciences (CRBU) Investor Presentations - Slideshow
May 17 NTLA 10 Biggest Losers in Cathie Wood’s Latest Portfolio
May 17 PSTX Poseida Therapeutics Presents Encouraging Preclinical Data Highlighting P-ckit-ALLO1 at the ASGCT 2022 Annual Meeting
May 16 CRBU Caribou Biosciences Presents Data on Mechanism Underlying Superior Specificity of Caribou’s chRDNA Genome-Editing Technology in Primary Human T cells
May 16 NKTX Nkarta Appoints David R. Shook, MD, as Vice President, Clinical Development
May 16 GRCL Gracell Biotechnologies Inc. (GRCL) CEO Dr. William Cao on Q1 2022 Results - Earnings Call Transcript
May 16 GRCL Gracell Biotechnologies GAAP EPS of -$0.07 in-line
May 16 GRCL Gracell Biotechnologies Reports First Quarter 2022 Unaudited Financial Results and Provides Corporate Update
May 16 GRCL Earnings Scheduled For May 16, 2022
May 15 PSTX Earnings Release: Here's Why Analysts Cut Their Poseida Therapeutics, Inc. (NASDAQ:PSTX) Price Target To US$16.25
May 15 ACET Results: Adicet Bio, Inc. Confounded Analyst Expectations With A Surprise Profit
Related Industries: Biotechnology Drug Manufacturers-General
Related Stock Lists: Immune System Medicine Biopharmaceutical Cancer Clinical Medicine Biotechnology Chimeric Antigen Receptor Gene Therapy Lymphoma Cancer Immunotherapy Life Sciences Solid Tumors Antigen Biology Breakthrough Therapy Cancer Treatment CD19 Hematopoietic Stem Cell Immunotherapy Leukemia

Browse All Tags